The PI3K signaling pathway has been established as a therapeutic target in bladder cancer (26) and pathways such as MYC, WNT, TGF-β, and PI3K have been shown to play critical roles in bladder cancer progression (27–30). The gene discussed is MYC; the disease is urinary bladder cancer.